Weiss Multi Strategy Advisers LLC Horizon Therapeutics Public LTD CO Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $206,841 - $241,279	-2,147 Reduced 1.67%	126,117 $13 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $544,434 - $575,785	-5,073 Reduced 3.8%	128,264 $14 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $5.77 Million - $10.5 Million	92,410 Added 225.79%	133,337 $15.2 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $1.43 Million - $2.06 Million	24,312 Added 146.33%	40,927 $2.53 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $3 Million - $4.4 Million	-37,794 Reduced 69.46%	16,615 $1.33 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $1.09 Million - $1.38 Million	12,591 Added 30.11%	54,409 $5.72 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $167,453 - $203,727	1,699 Added 4.23%	41,818 $4.51 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $97,792 - $117,433	-1,064 Reduced 2.58%	40,119 $4.4 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $126,859 - $141,098	1,471 Added 3.7%	41,183 $3.86 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $236,177 - $313,938	-3,288 Reduced 7.65%	39,712 $3.66 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $469,000 - $590,730	7,000 Added 19.44%	43,000 $3.15 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $1.38 Million - $2 Million	25,000 Added 227.27%	36,000 $2.8 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $47,142 - $88,945	1,561 Added 16.54%	11,000 $611,000
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $212,912 - $330,112	-8,561 Reduced 47.56%	9,439 $280,000
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $25,430 - $36,670	1,000 Added 5.88%	18,000 $652,000
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $387,770 - $484,160	17,000 New	17,000 $409,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Account